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Summary. Survival analysis is often used to compare experimental and conventional treatments. In ob-
servational studies, the therapy may change during follow-up and such crossovers can be summarized by
time-dependent covariates. Given the ever-increasing donor organ shortage, higher-risk kidneys from ex-
panded criterion donors (ECD) are being transplanted. Transplant candidates can choose whether to accept
an ECD organ (experimental therapy), or to remain on dialysis and wait for a possible non-ECD transplant
later (conventional therapy). A three-group time-dependent analysis of such data involves estimating param-
eters corresponding to two time-dependent indicator covariates representing ECD transplant and non-ECD
transplant, each compared to remaining on dialysis on the waitlist. However, the ECD hazard ratio estimated
by this time-dependent analysis fails to account for the fact that patients who forego an ECD transplant
are not destined to remain on dialysis forever, but could subsequently receive a non-ECD transplant. We
propose a novel method of estimating the survival benefit of ECD transplantation relative to conventional
therapy (waitlist with possible subsequent non-ECD transplant). Compared to the time-dependent analysis,
the proposed method more accurately characterizes the data structure and yields a more direct estimate of
the relative outcome with an ECD transplant.
Key words: Cohort study; Failure time data; Matching; Proportional hazards model; Risk set; Survival
analysis.
1. Introduction
End-stage renal disease (ESRD; also known as chronic kid-
ney failure) is increasing in many countries worldwide and
has become a major public health issue due to its associated
mortality and health care cost. Patients with renal failure
must receive either dialysis or a kidney transplant in order to
remain alive. Medically suitable patients are placed on a wait-
ing list in order to receive a cadaveric renal transplant. Gen-
erally, mortality rates are significantly lower post-transplant
compared to those on the waitlist (WL) (Wolfe et al., 1999;
Rabbat et al., 2000). Due to the ever-increasing shortfall in
availability of donor organs, patients are electing to receive a
cadaveric organ from an expanded criterion donor (ECD) with
increasing frequency. Port et al. (2002) formally quantified
the term “ECD” to apply to deceased donors in whom trans-
planted kidneys are associated with more than a 70% increase
in transplant failure, compared to a non-ECD kidney. Com-
parisons between ECD and non-ECD transplant outcomes are
useful, but a more relevant comparison is between accepting
an ECD transplant and “conventional therapy,” which is to
remain on the WL with the potential to subsequently receive
a non-ECD transplant.
The Cox (1972) proportional hazards model provides an
extremely flexible way to make covariate-adjusted mortal-
ity comparisons among therapies when a patient’s mode of
therapy may change over time. The model is widely used for
survival analysis and is readily accepted by clinicians. As ap-
plied to the current setting, where there are three mutually
exclusive “states” (WL dialysis, ECD transplant, and non-
ECD transplant), time-dependent indicator covariates could
be set up for the two transplant states and a proportional haz-
ards analysis could be carried out in a straightforward man-
ner. The estimated hazard ratio (HR) for ECD would reflect
the mortality contrast between an ECD transplant and dial-
ysis on the WL. In interpreting the ECD/WL hazard ratio,
patients currently on the WL could determine the reduction
in mortality hazard which would apply at that point in time
if they received an ECD transplant compared to remaining
on the waitlist.
Although informative, this “three-group time-dependent”
(T3) analysis does not address the choice faced by the candi-
date. The question for the patient is not “Would I be better off
with an ECD transplant than being on dialysis?” but, rather,
“Would I be better off accepting an ECD organ, given that,
if I do not accept it, I could subsequently be offered a non-
ECD organ?” The “experimental” group is ECD transplant.
However, the “conventional therapy” group is not “waitlist,”
but, rather, “refusing the ECD organ and possibly receiving
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a non-ECD kidney in the future.” The ECD/WL hazard ra-
tio, as estimated by the T3 method, applies while the pa-
tient remains on the WL; should the patient subsequently
receive a non-ECD transplant, a different HR would apply.
The ECD/WL parameter, as estimated by the standard time-
dependent method, does not pertain to the contrast between
the experimental and conventional therapy.
On the surface, the problem appears to be reduced to a
two-group time-dependent problem, with candidates crossing
over from the standard therapy group to the ECD group.
Analysis of these data with a single time-dependent covariate
would appear to address the comparison of interest. However,
two complications are described below that suggest that such
a “two-group time-dependent” (T2) analysis will yield biased
results.
One complication involves removal from the waitlist. Pa-
tients who become too ill to undergo transplantation are of-
ten removed from the WL. How should the follow-up time for
such candidates be included in the analysis? Since unlisted
dialysis patients are not transplant candidates, it is inappro-
priate to include them in the comparison group for transplant
recipients. It would seem appropriate to censor patients at
the time of removal from the WL, since they are no longer
eligible to receive either an ECD or a non-ECD transplant.
However, removal can be considered an intermediate event on
the pathway from the currently administered dialysis therapy
to the event of interest, mortality. With an ideal surveillance
of patient condition, all patients might, at some point prior
to death, be deemed unsuitable transplant candidates and re-
moved from the WL. If such removals were censored, then WL
mortality would be estimated to be 0, due to the informative
censoring. It appears that both options, censoring at removal
or including follow-up after removal, lack face validity.
Another complication arises from the inclusion of non-ECD
transplant recipients in the standard therapy group. A naive
two-group analysis might include the follow-up for all non-
ECD transplant recipients in the standard therapy group, in-
cluding that of pre-existing non-ECD transplants. However,
a candidate who is offered an ECD organ has the option of
waiting for a future non-ECD transplant, but does not have
the option of going back in time to receive a non-ECD organ
prior to the offer of the ECD organ. Pre-existing non-ECD
transplants should not be included in the standard therapy
group.
We propose a “sequential stratification” method which, un-
like the T3 analysis, yields treatment parameters that have an
interpretation that addresses the choice faced by the candi-
date and which, unlike the T2 analysis, avoids the two com-
plications described in the previous two paragraphs. In or-
der to address the complications described above, the method
employs matching to create a series of strata for each ECD
transplant, which includes only those patients who are eli-
gible for transplant and which also includes follow-up times
after removal from the WL. The proposed method uses re-
moval and prior transplant information from the data struc-
ture in order to avoid the two biases described above. Under
the proposed method, prior removals from the WL and non-
ECD transplants are appropriately excluded from the stra-
tum while subsequent follow-up after removal from the WL is
included.
Using the proposed sequential stratification method, a sig-
nificant survival benefit of ECD kidney transplantation is
demonstrated, relative to remaining on the WL and possibly
subsequently receiving a non-ECD organ.
The remainder of this article is organized as follows. In
Section 2, we set up the requisite notation and formal-
ize the problem. The standard (T3) time-dependent propor-
tional hazards analysis and the T2 method are described in
Section 3. In Section 4, we re-examine the organ failure/
transplant data structure, then propose our alternative
method of analysis in Section 5. The survival benefit of ECD
transplant is assessed using the proposed method in Section
6, with concluding remarks provided in Section 7.
2. Notation on Data Sources
We first present notation for latent variables, which might
not be observed for all subjects. Let Di represent the time
of death for patient i, for i = 1, . . . , n. Censoring time due
to end of study or loss to follow-up is denoted by Ci . Since
living-donor organs are not of interest in this analysis, patients
are censored if and when they receive a transplant from a
living donor. The time of cadaveric transplant is denoted by
Ti = T
E
i ∧ T Ēi , where TEi is the time of ECD transplant, T Ēi is
the time of non-ECD transplant, and a ∧ b = min{a, b}. The
time at which a patient is removed from the WL is denoted
by Ri .
Notation for the observed data is given here. The death
indicator is defined as Δi = I(Di < Ci ), with correspond-
ing counting process Ni (t) = I(Xi ≤ t)Δi, where Xi = Ci ∧
Di is the observation time for subject i. The covariate vector
is given by Zi (t). The stratum, described later, for patient i
is denoted by si . We make the familiar independent censor-
ing assumption. That is, we assume that Ci is conditionally
independent of Di , given Zi (t) and si ; specifically,
lim
δ↓0
P (t ≤ Di < t + δ |Di > t,Ci > t,Zi(t), si)
= lim
δ↓0
P (t ≤ Di < t + δ |Di > t,Zi(t), si).
As such, since living-donor transplants are absorbed into Ci ,
we assume that the receipt of a living-donor transplant does
not depend on the mortality hazard the patient would have
faced had they remained on the WL.
Data were collected by the Organ Procurement and Trans-
plantation Network and obtained from the Scientific Reg-
istry for Transplant Recipients (SRTR). The study popula-
tion included patients (n = 97,619) initially waitlisted in the
United States, aged ≥18 years, between January 1, 1998 and
December 31, 2002. The observation period concluded at the
end of 2002. The time origin (t = 0) for a given patient was the
date that patient was initially placed on the kidney transplant
waiting list. Stratification was by age (single year) and re-
gion, while gender, race, and underlying cause of renal disease
were represented in the covariate vector. Age is well known
to be a strong predictor of mortality among transplant pa-
tients. In addition, separate waitlists are maintained at the
60 organ procurement organizations (OPOs) in the United
States, which are defined geographically (by state, approxi-
mately). Socioeconomic status, general baseline health, and
other factors which could affect mortality are known to differ
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geographically. Hence, careful adjustment of age and OPO is
required in any meaningful comparison between therapies.
3. Standard Time-Dependent Methods
In this section, we describe two existing methods of analysis,
beginning with the T3 analysis and followed by the T2 analy-
sis. The Cox (1972) proportional hazards model is assumed.
3.1 Three-Group Time-Dependent Analysis
We now describe the T3 analysis of the evaluation of the mor-
tality risk of expanded criterion donor transplant relative to
dialysis on the WL. The proportional hazards model is given
by





where si is the stratum for patient i, λ0j (t) is an unspecified
stratum-specific baseline hazard, and Zi (t) is a vector of time-
dependent covariates that include I(TEi ≤ t), I(T Ēi ≤ t), and
terms for the adjustment covariates, which included gender,
race, and disease leading to renal failure.
At time t, each patient who is alive and uncensored
is classified into one of three mutually exclusive time-
dependent “treatments”—WL, ECD transplant, or non-ECD
transplant—by I(TEi ≤ t) and I(T Ēi ≤ t). The coefficient of
I(TEi ≤ t), the indicator for ECD transplant, is denoted by
βE0 , which is a component of β0. The regression parameter,
β0, is estimated through partial likelihood (Cox, 1975) as the
solution to the estimating equation Uβ(β) = 0, where 0 is








{Zi(s) − Z̄j(s;β)}Yij(s)dN i(s),









with τ typically set to max{X1, . . . ,Xn} such that all observed
deaths contribute to the analysis. Notice that Ri is ignored in
this analysis, essentially.
Results based on this approach are presented in Table 1.
It is shown that ECD transplant recipients have a covariate-
adjusted mortality HR of 0.83, relative to waitlisted patients
on dialysis (p < 0.0001), with 95% confidence interval (0.76,
0.91).
This three-group analysis gives an informative description
of the contrast between ECD transplant and WL mortality.
Table 1
Hazard ratios estimated by three-group time-dependent
(T3) method
Group exp{β̂} (95% CI) p-value
WL 1 – –
ECD transplant 0.83 (0.76, 0.91) <0.0001
Non-ECD transplant 0.55 (0.52, 0.58) <0.0001
At any time t, a patient with an ECD transplant has a mor-
tality hazard which is 83% that of a comparable waitlisted
patient at time t, reflecting, for a patient on the WL, the
reduction in mortality they could expect to reap upon ECD
transplantation.
Renal failure patients must receive either dialysis or a kid-
ney transplant; hence dialysis and transplantation are mutu-
ally exclusive and exhaustive states. If we were interested in
comparing WL and transplantation (be it ECD or non-ECD),
then defining the covariate I(Ti ≤ t) and using this standard
time-dependent analysis address the question of interest, as
applied by Wolfe et al. (1999). However, the question is dif-
ferent when interest lies in one of the two transplant types
(i.e., ECD or non-ECD). Patients can forego an ECD, with
the objective of subsequently receiving a non-ECD organ.
The T3 analysis compares all three therapies and includes
a comparison of mortality after transplantation with an ECD
organ to mortality while remaining on the WL. However, the
comparison of interest is between the “experimental therapy”
(i.e., ECD transplant) and “conventional therapy” (foregoing
an ECD transplant and remaining on the WL, with the op-
portunity to subsequently receive a non-ECD organ). There
is no treatment group in the T3 analysis that corresponds to
conventional therapy; thus, the three-group time-dependent
analysis does not estimate the comparison of interest.
3.2 Two-Group Time-Dependent Analysis
In the T3 analysis described in the preceding subsection, pa-
tients on the WL have their WL mortality censored upon
receipt of a transplant. This censoring of WL mortality can
be considered independent censoring, since patients are or-
dered on the WL primarily based on waiting time, rather than
upon patient condition. Transplanted subjects contribute two
follow-up subintervals to the analysis; the first subinterval
spans the time from waitlisting to transplant (ECD or non-
ECD), while the second spans the time from transplant to the
end of follow-up. Since conventional therapy includes both the
waitlist interval and the interval after a non-ECD transplant,
it seems natural to not censor a WL patient’s follow-up upon
non-ECD transplantation. We refer to this method of analysis
as the two-group time-dependent analysis (T2). Again using
a proportional hazards model, estimation proceeds as in the
T3 analysis, but with I(T Ēi ≤ t) removed from Zi (t). The pa-
rameter vector now is denoted by γ0, with γ
E
0 denoting the
component of γ0 corresponding to I(TEi ≤ t).
Results from the modified time-dependent analysis are pre-
sented in Table 2.
The ECD and “WL + non-ECD” groups have virtually
equal mortality hazard, with exp{γ̂E} = 1.01 (0.93, 1.10) and
p = 0.80. Taking these results at face value, there appears to
be no benefit of opting for an ECD transplant. As indicated
Table 2
Hazard ratios estimated by two-group time-dependent
(T2) method
Group exp{γ̂} (95% CI) p-value
WL + non-ECD 1 – –
ECD transplant 1.01 (0.03, 1.10) 0.80
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by the T3 analysis, mortality is highest for the WL group
and lowest for the non-ECD group; so the result from the T2
analysis, which combines these together into the conventional
therapy group, is not surprising.
The conventional therapy group in the T2 analysis includes
all non-ECD transplant during follow-up. At any moment
of time, the conventional therapy group in the T2 analysis
already includes a substantial fraction of existing non-ECD
transplant recipients. However, the offer of an ECD trans-
plant at time t is conditional upon being in the WL group
(I{Ti ≤ t} = 0), so the conventional therapy group in the T2
analysis does not represent an option available to the ECD
candidate at the time an ECD kidney is offered.
In addition, it should be noted that neither the T3 nor the
T2 analyses explicitly deal with removal from the WL. In the
next two paragraphs, we argue that removal from the waitlist
should be used to determine entry into the conventional ther-
apy group, but should not be used to censor follow-up after
entry into the WL group.
First, we discuss entry into the conventional therapy group.
Not all patients on dialysis are waitlisted, and an analysis by
Wolfe et al. (1999) revealed higher mortality risk for non-
WL, relative to WL, dialysis patients. Mortality comparisons
should be based on groups who satisfy similar eligibility cri-
teria. In determining the appropriate comparison group for
cadaveric kidney transplant patients, it is important to con-
sider only WL patients, since dialysis patients who are not on
the WL are not eligible to receive a cadaveric organ. Similarly,
follow-up for patients who have been previously removed from
the WL should not be included in the comparison group for
ECD transplants.
Second, we discuss censoring after removal from the WL
group. If a transplant fails, patients are not censored from
the transplant group. Rather, an intent-to-treat approach is
adopted, wherein potential graft failure is considered to be
an assumed risk of transplantation. Similarly, WL patients
should not be censored upon removal from the WL. In the vast
majority of cases, patients are removed from the WL because,
in the opinion of their physician, they have become too ill
or weak to withstand surgery. Thus, if the organ allocation
system operated perfectly, observed WL mortality would be
0, since patients would be too sick to undergo transplantation
in the moments before they die.
In summary, the T2 analysis better captures the possibil-
ity of future non-ECD transplantation in the specification of
conventional therapy, relative to the T3 analysis. However,
the T2 approach fails in two ways in its attempt to define
conventional therapy. First, it includes pre-existing non-ECD
transplants. Second, the method of handling removals from
the WL lacks face validity. Since parameters based on either
the standard time-dependent analysis (T3) or the simple mod-
ification thereof (T2) do not have the desired interpretations,
a new method of analysis is required.
4. The Ideal Study and the ECD Transplant
Experiment
Ideally, to measure the survival benefit associated with ex-
panded criterion donor transplantation, a randomized con-
trolled trial would be conducted. Each time an ECD kidney
was procured, one patient from the WL would be randomly
selected to receive the transplant, with the rest remaining on
the WL. Such a trial will never occur, due to ethical and logis-
tical considerations. Notwithstanding, it is useful to consider
the data structure generated by this ideal experiment.
In reality, patients are not randomized to receive or not
receive ECD organs. However, each ECD transplant can be
considered to be one replicate of an experiment; one patient
receives the transplant, while the rest remain on the WL, with
the option of subsequent non-ECD transplant (i.e., conven-
tional therapy). An intent-to-treat approach is appropriate for
the analysis of this experiment. Thus, patients remain in the
conventional therapy group if they receive a non-ECD trans-
plant, since potential non-ECD transplantation is one com-
ponent of conventional therapy. Also, patients who had been
removed from the WL prior to the time of the experiment-
generating transplant are not eligible for (are excluded from)
the control group, since they are not eligible for an ECD
transplant. However, patients would not be censored from the
control group at removal from the WL after the experiment
begins. Following the intent-to-treat concept starting at the
time of entry in each experiment, baseline covariates for each
experiment are defined by the current value of time-dependent
covariates, at the time each experiment starts. As in standard
time-dependent crossover analyses, the conventional therapy
patients are censored from the conventional therapy group
and enter another ECD experiment at the time of ECD trans-
plantation.
These considerations suggest an alternative method of anal-
ysis, which we now propose.
5. Proposed Method: Sequential Stratification
In this section, we formalize the analysis of the ECD trans-
plant “experiments” suggested in Section 4. An experiment is
said to begin each time an ECD transplant occurs. It is con-
venient to order the ECD transplant times, first to last, by




i < Xi) is the
total number of observed ECD transplants. Correspondingly,
we order the strata from which the ECD transplants arose as
s(1), . . . , s(nE ). At the time of the th ECD transplant, the
“experimental” group consists of the patient receiving the
ECD transplant. The control group consists of all patients
who are comparable to the experimental patient and were
eligible to receive the ECD transplant at time t = t() but
did not. “Comparability” requires that the control patient be
from the same stratum as the ECD patient; that is, si = s(),
for subject i. “Eligibility,” for patient i, requires that patient
i has not received a transplant, has not been removed, and is
still under observation at time t = t(). We formalize these cri-




TEi ≥ t(), T Ēi ∧Xi ∧Ri > t(), si = s()
}
,
which equals 1 for patients eligible for the th experiment and
0 otherwise. Although patients are required to not have been
transplanted or removed from the WL at time t() to enter
the th experiment, patients are not censored from the th
experiment if they are removed or if they receive a non-ECD
transplant, since both of these events are part of conventional
therapy. If they receive an ECD organ during the th ex-
periment, they are censored from that experiment and their
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ECD transplant would initiate a separate experiment. Corre-
spondingly, the risk set indicator for subject i can be written
as Yi()(s) = Yi(s)I{TEi > s}I{Ti =t()}, with respect to the th
experiment, where Yi (s) = I{Xi ≥ s}.
The hazard function for subject i in this th experiment is
given by





where θ0 is a vector of unknown parameters corresponding to







t ≤ Di < t + δ |Di > t, TEi ≥ t(),
T Ēi ∧Xi ∧Ri > t(),Zi() = 0
}
is the experiment and stratum-specific baseline hazard, which
corresponds to the hazard function for the conditional random
variate, (Di |Ti ∧ Ri > t()). We denote θE as the element of
interest from θ0; that is, the element which corresponds to
I{TEi = t()}.
We now derive the estimating equation for θ0. To begin, we




λi()(s;θ) ds}, which is a martingale with respect to the filtra-
tion Fi()(t) = σ{ei(), Ni(s−), Yi()(s),Zi(); s ∈ [t(), t]}. The
fact that E[Mi()(t;θ0) | Fi()(t)] = 0 leads to the follow-





















The estimating function in (1) can be derived using standard
partial likelihood (Cox, 1975) theory and can be easily shown
to have mean zero at θ = θ0 through standard martingale





ei(){Zi() − Z̄()(s;θ)}Yi()(s) dN i(s), (2)
simply through the definitions of Z̄()(s;θ) and dMi()(s; θ).
Aggregating across all strata, we propose to estimate θ0 by














Essentially, (3) corresponds to a stratified Cox model, with
strata defined by ECD transplant times, {t();  = 1, . . . , nE},
and covariates used to define si . Thus, Uθ(θ) = 0 can be
solved using standard proportional hazards regression soft-
ware, such as phreg in SAS and coxph in R/Splus. At each ECD
transplant time, strata are set up. Consider the th-ordered
ECD transplant. Using the (start, stop, event indicator) no-
tation, the patient receiving the th ECD organ (say, patient
j) contributes (t(), Xj , Δj); patients with si = sj (i = j) with
Ri ∧ Xi ∧ Ti > t() are included in the stratum and contribute
(t(), Xi ∧ TEi , ΔiI{Di < TEi }).
The consistency of θ̂ can be proven using straightfor-
ward extensions of techniques presented in Anderson and Gill
(1982). Proof of the asymptotic normality of n1/2(θ̂ − θ0) is
more complicated and beyond the scope of the current report.
Speaking generally, the conditions underlying the derivations
of existing robust techniques, such as those developed by
Bilias, Gu, and Ying (1997) and Wei, Lin, and Weissfeld
(1989) and applied by several authors (e.g., Lin et al., 2000),
do not hold. One complicating feature is that Z̄()(s;θ0) need
not converge to a limit, z̄()(s;θ0) for any time, s, at least in
a continuous time framework. A second difficulty involves de-
termining the contribution, asymptotically, of each individual,
in the presence of an estimating equation which is essentially
a double summation across all subjects.
Consequently, we propose estimating the distribution of θ̂
empirically through the bootstrap (Efron, 1982). That is, in-
dividual patients are randomly resampled B times, where B
is a large number. Let θ̂b represent the estimator of θ0 based
on the bth resample. The covariance matrix of θ̂ is estimated
by
Σ̂θ = (B − 1)−1
B∑
b=1
(θ̂b − θ̂)(θ̂b − θ̂)T .
Hypothesis tests of the form H0 :θ0 = 0 versus H1 :θ0 =





to follow a chi-square distribution with degrees of freedom
equal to number of elements in θ0. This Wald test assumes an
asymptotic normal distribution for n1/2(θ̂ − θ0). If diagnostic
plots (e.g., histograms, q/q plots) of the {θ̂k,b; b = 1, . . . , B}
display great departure from normality, confidence intervals
and hypothesis tests could be based on the bootstrapped per-
centiles, although this would require choosing a much larger
value of B (e.g., B = 10,000).
6. Application of Sequential Stratification
Method to Renal Failure Data
As stated in Section 5, for the experiment generated by
the th ECD transplant, the proposed method involves es-
timating multiplicative effects on the hazard function for
(Di | ei() = 1). Thus, each experiment only consists of one
ECD transplant patient. We assumed that λ0(k)(t) ≈ λ0()(t)
when t(k) ≈ t(). As such, prior to applying the sequential
stratification method, we grouped strata with the same age
and organ procurement organization by the week of ECD
transplant. In addition to I{TEi ≤ t}, components of Zi()
included terms for gender, race, and cause of end-stage renal
disease, as in the T3 and T2 analyses.
Results of the sequential stratification analysis are pre-
sented in Table 3. The hazard ratio for ECD relative to stan-
dard therapy is estimated at HR = 0.89 (0.81, 0.96). There-
fore, based on the proposed method, ECD transplantation is
associated with a significant (p = 0.02) reduction in mortal-
ity, relative to remaining on the WL with the possibility of
receiving a non-ECD transplant in the future.
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Table 3
Hazard ratios estimated by proposed sequential
stratification method
Group exp{θ̂} (95%CI) p-value
Conventional therapy 1 – –
ECD transplant 0.89 (0.81, 0.96) 0.02
Results in Table 3 are based on 500 bootstrap replications,
with the confidence intervals and p-values obtained through
the normal approximation. For each bootstrap replicate, it
took approximately 15 minutes to compute β̂b. All program-
ming was done using SAS (v8.2).
Model diagnostics mostly centered around (i) the normality
assumption, upon which inference was based and (ii) the as-
sumption that θE was constant across t1, . . . , tnE . As indicated
by the plots of the θ̂E,b’s (Figure 1), the normal approxima-
tion appears to be quite reasonable.
The proposed method assumes that the ECD regression
parameter is equal across several conditional mortality haz-
ards, with the conditionality depending on the time of ECD
transplant. This is a rather strong assumption that may fail
frequently in practice. Fortunately, it can be evaluated em-
pirically through interaction terms. For example, in our anal-
ysis, to examine the validity of this assumption, we fitted a
model using the proposed method which allowed for sepa-




E , and θ
4+
E , per-
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Figure 1. Histogram, box/whisker, q/q plot, and smoothed density of θ̂Eb , based on B = 500 bootstrap resamples.
tal model, the hazard ratios were estimated at exp{θ̂1E} =
0.91 (0.81, 1.02) for year 1, exp{θ̂2E} = 0.85 (0.73, 0.99) in
year 2, exp{θ̂3E} = 0.92 (0.73, 1.15) in year 3, and exp{θ̂4+E } =
0.89 (0.63, 1.26) in years 4–5. The random scatter of these
estimated hazard ratios around the overall value, HR = 0.89,
supports the assumption that the ECD hazard ratio is inde-
pendent of time of transplant.
7. Concluding Remarks
We propose a sequential stratification method of survival
analysis, useful for estimating the effect of a time-dependent
treatment in the presence of other time-dependent treat-
ments. We applied the proposed method to compare expanded
criterion donor kidney transplantation versus conventional re-
nal replacement therapy, the latter being defined as not re-
ceiving an ECD organ, with the possibility of future non-ECD
transplant. The method features a natural characterization of
the kidney failure/transplant data structure.
Although we discuss the proposed method mostly in the
context of renal failure, the setting which motivated its devel-
opment, the method has wide applicability to observational
studies where time to a terminal event is of interest and the
treatments being compared are time dependent.
Our analytical objective was to determine whether there
is a benefit, with respect to patient survival, of accepting
an ECD kidney, compared to the conventional idea of not
accepting an ECD organ and remaining on the WL in the
hope of obtaining a non-ECD transplant. The standard T3
three-group time-dependent analysis uses a three-level time-
dependent covariate, with mutually exclusive categories: WL,
ECD, and non-ECD. Using this approach, ECD is shown to be
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superior to the WL. However, this analysis does not address
the research question of interest, since the “WL” group does
not represent conventional therapy, as conventional therapy
includes the possibility of a future non-ECD transplant.
A modification to the T3 method, T2, involves not censor-
ing the WL follow-up of patients who receive a non-ECD kid-
ney and, hence, reduces the number of comparison groups to
two. This modified time-dependent method essentially com-
bines the WL and non-ECD experience. When applied to the
renal failure data, there appeared to be virtually no differ-
ence in mortality between ECD and “WL and non-ECD.”
The ECD regression parameter estimated by this method is
difficult to interpret because prior non-ECD transplants and
removals from the waitlist are handled inappropriately.
The proposed method is targeted at observational data,
with the objective of reconstructing the parameter estimate
for an experimental treatment that would have been esti-
mated by a randomized controlled trial. Although covari-
ate imbalances between the experimental and conventional
therapy groups can be accommodated through covariate ad-
justment and stratification, such adjustments may be in-
complete. For example, patients who choose to receive an
ECD organ may exhibit certain unmeasured characteristics
which distinguish them from patients who opt for conven-
tional therapy. Therefore, due to the observational nature
of the data, unmeasured patient selection factors may bias
the estimated regression parameter. Of course, clinical trials
are not subject to this sort of limitation. It is possible that
a propensity score approach (Rosenbaum and Rubin, 1983)
may be an alternative to, or an enhancement of, the proposed
method.
In the analysis of organ failure data, careful consideration of
the censoring mechanisms is usually warranted. Patients who
are transplanted are not censored; with transplantation coded
as a time-dependent covariate, they would continue to con-
tribute to the analysis as “transplanted.” But, transplanted
patients are censored with respect to their waitlist mortality.
In the context of kidney transplantation, such censoring would
be largely independent since deceased-donor kidneys are allo-
cated primarily based on waiting time. However, for chronic
liver failure patients, dependent censoring would be a major
concern since (under the new allocation scheme which took
effect in early 2002), patients are sequenced on the WL, es-
sentially, in decreasing order of WL mortality risk. Therefore
waitlisted patients with the greatest transplant rate are also
those with the greatest WL mortality risk. Extension of the
proposed methods to accommodate such dependent censoring
is currently underway.
Results based on the proposed sequential stratification
method indicate a significant 11% reduction in mortality as-
sociated with ECD kidney transplantation. Patients decid-
ing whether to accept an ECD organ would want to consider
the experience of similar patients faced with the same deci-
sion. The sequential stratification analysis indicates that pa-
tients waitlisted between 1998 and 2002 who accepted an ECD
transplant demonstrated a significant 11% decrease in mortal-
ity compared to patients who received conventional therapy.
Patients and clinicians should consider these findings care-
fully, particularly given the ever-increasing shortage of donor
organs.
Future work will involve further examination of the large-
sample properties of the regression parameter estimator
for the proposed method. Although arguments to demonstrate
the regression parameter’s consistency are straightforward,
the asymptotic distribution is difficult to derive. As such, the
bootstrap was employed in the ECD analysis. Due to our
current reliance on the bootstrap for inference, the size of the
data set (n = 97,619) limits the depth of the analysis. For
now, we describe the benefit of ECD transplantation in the
overall sense, that is, averaged across patient subgroups. It is
possible that HR of exp{θ̂E} = 0.89 under- or overestimates
the effect of ECD kidney transplantation for certain patient
subgroups. Future analyses, to be reported in the medical lit-
erature, will estimate the ECD survival benefit separately for
each major demographic and clinical cross-classification.
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